Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Vink

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Methods (San Diego, Calif.)|July 23, 2013
A simple, robust and highly efficient transient expression system for producing antibodiesTom Vink, Maroeska Oudshoorn-Dickmann, Marcel Roza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2012
Crosstalk between human IgG isotypes and murine effector cellsMarije B Overdijk, Sandra Verploegen, Antonio Ortiz Buijsse, et al.
Annals of the New York Academy of Sciences|July 10, 2003
Melanocortin system and eating disordersRoger A H Adan, Jacquelien J G Hillebrand, Corine De Rijke, et al.
Biotechnology Progress|February 19, 2009
N-linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgGPatrick H C van Berkel, Jolanda Gerritsen, Gerrard Perdok, et al.
Blood|November 8, 2008
Complement activation impacts B-cell depletion by both type I and type II CD20 monoclonal antibodiesFrank J Beurskens, Sigrid R Ruuls, Patrick J Engelberts, et al.
Biotechnology and Bioengineering|September 10, 2009
Rapid production of recombinant human IgG With improved ADCC effector function in a transient expression systemPatrick H C van Berkel, Jolanda Gerritsen, Edwin van Voskuilen, et al.
Molecular Cancer Therapeutics|August 26, 2016
Efficient Payload Delivery by a Bispecific Antibody-Drug Conjugate Targeting HER2 and CD63Bart E C G de Goeij, Tom Vink, Hendrik Ten Napel, et al.
Mabs|February 15, 2013
Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgGRebecca J Rose, Patrick H C van Berkel, Ewald T J van den Bremer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2011
Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibitionMarije B Overdijk, Sandra Verploegen, Jeroen H van den Brakel, et al.
Mabs|February 5, 2014
HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate designBart E C G de Goeij, Matthias Peipp, Simone de Haij, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods (San Diego, Calif.)|July 23, 2013
A simple, robust and highly efficient transient expression system for producing antibodiesTom Vink, Maroeska Oudshoorn-Dickmann, Marcel Roza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2012
Crosstalk between human IgG isotypes and murine effector cellsMarije B Overdijk, Sandra Verploegen, Antonio Ortiz Buijsse, et al.
Annals of the New York Academy of Sciences|July 10, 2003
Melanocortin system and eating disordersRoger A H Adan, Jacquelien J G Hillebrand, Corine De Rijke, et al.
Biotechnology Progress|February 19, 2009
N-linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgGPatrick H C van Berkel, Jolanda Gerritsen, Gerrard Perdok, et al.
Blood|November 8, 2008
Complement activation impacts B-cell depletion by both type I and type II CD20 monoclonal antibodiesFrank J Beurskens, Sigrid R Ruuls, Patrick J Engelberts, et al.
Biotechnology and Bioengineering|September 10, 2009
Rapid production of recombinant human IgG With improved ADCC effector function in a transient expression systemPatrick H C van Berkel, Jolanda Gerritsen, Edwin van Voskuilen, et al.
Molecular Cancer Therapeutics|August 26, 2016
Efficient Payload Delivery by a Bispecific Antibody-Drug Conjugate Targeting HER2 and CD63Bart E C G de Goeij, Tom Vink, Hendrik Ten Napel, et al.
Mabs|February 15, 2013
Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgGRebecca J Rose, Patrick H C van Berkel, Ewald T J van den Bremer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2011
Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibitionMarije B Overdijk, Sandra Verploegen, Jeroen H van den Brakel, et al.
Mabs|February 5, 2014
HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate designBart E C G de Goeij, Matthias Peipp, Simone de Haij, et al.
Pageof 2